August 2022: TempTraq by Blue Spark Technologies Inc

Early fever detection leads to better patient care.

Image credit: PR Newswire

Blue Spark Technologies Inc produces TempTraq, an FDA Cleared Class II medical device that gives Healthcare providers the first wireless continuous temperature monitor in the form of a soft, comfortable, disposable patch. TempTraq can significantly improve the way temperature is measured in the clinical environment and provides clinicians with a quicker, easier, and more effective way to measure temperature.

Accuracy and equivalency in three hospital studies:
  • Cleveland Clinic
  • University Hospitals Seidman Cancer Center
  • Cincinnati Children’s Hospital

 

In a clinical study conducted by University Hospitals Seidman Cancer Center, TempTraq was shown to detect temperature rises earlier than the standard of care by a median of 140.1 minutes (range of 30-180 minutes) with bone marrow transplant patients.

WT thinks this is what earns TempTraq the title “Innovation of the Month”.

Jürgen Thalmayer
August 1, 2022

August 2022

Innovation of the month

Do you want to discover more, visit the website
Vist webiste

Other news

New Partnership to Power the Future of Birth Control

Natural Cycles partners with the Oura Ring to monitor temperature for the birth control app.

Apple Reportedly Looking to Add Blood Pressure Monitoring and Fertility Tracking In Smartwatch

Apple’s next watch may have blood pressure monitoring and a thermometer to help with fertility ...

Mount Sinai Chooses Current Health’s Remote Patient Monitoring to Provide Patients Equal Access to Cancer Care

Founded in 1852, Mount Sinai is one of the oldest and largest teaching hospitals in the United ...

Biofourmis Raises Another $20M from Intel Capital

Intel Capital joined Biofourmis' Series D financing in an extension. Total funding stands at $320M.
Discover more